Abbott Laboratories Stock Performance
| ABT Stock | USD 125.64 0.19 0.15% |
The firm shows a Beta (market volatility) of 0.35, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Abbott Laboratories' returns are expected to increase less than the market. However, during the bear market, the loss of holding Abbott Laboratories is expected to be smaller as well. At this point, Abbott Laboratories has a negative expected return of -0.0303%. Please make sure to confirm Abbott Laboratories' standard deviation, kurtosis, relative strength index, as well as the relationship between the maximum drawdown and day median price , to decide if Abbott Laboratories performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Abbott Laboratories has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable fundamental drivers, Abbott Laboratories is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors. ...more
Actual Historical Performance (%)
One Day Return (0.15) | Five Day Return 2.45 | Year To Date Return 10.75 | Ten Year Return 146.11 | All Time Return 76.2 K |
Forward Dividend Yield 0.0188 | Payout Ratio | Forward Dividend Rate 2.36 | Dividend Date 2025-08-15 | Ex Dividend Date 2025-07-15 |
| Abbott Laboratories dividend paid on 15th of May 2025 | 05/15/2025 |
1 | Quinta Brunson Looking Forward To Roles Beyond Abbott Elementary | 07/02/2025 |
2 | More than 160 people are still missing after Texas deadly floods, Gov. Abbott says | 07/08/2025 |
3 | Voices Diane Abbott may not be right but is she entirely wrong on race | 07/18/2025 |
4 | J.W. Cole Advisors Inc. Acquires 12,246 Shares of Abbott Laboratories | 07/21/2025 |
5 | NVST or ABT Which Is the Better Value Stock Right Now | 07/22/2025 |
6 | CD40CD40L Inhibitors Market on Growth Trajectory Driven by Advancements in Autoimmune and Cancer Therapeutics DelveInsight | 07/24/2025 |
| Begin Period Cash Flow | 6.9 B | |
| Total Cashflows From Investing Activities | -2.3 B |
Abbott Laboratories Relative Risk vs. Return Landscape
If you would invest 12,895 in Abbott Laboratories on April 26, 2025 and sell it today you would lose (331.00) from holding Abbott Laboratories or give up 2.57% of portfolio value over 90 days. Abbott Laboratories is generating negative expected returns assuming volatility of 1.5606% on return distribution over 90 days investment horizon. In other words, 13% of stocks are less volatile than Abbott, and above 99% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Abbott Laboratories Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Abbott Laboratories' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Abbott Laboratories, and traders can use it to determine the average amount a Abbott Laboratories' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0194
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ABT |
Estimated Market Risk
| 1.56 actual daily | 13 87% of assets are more volatile |
Expected Return
| -0.03 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.02 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Abbott Laboratories is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Abbott Laboratories by adding Abbott Laboratories to a well-diversified portfolio.
Abbott Laboratories Fundamentals Growth
Abbott Stock prices reflect investors' perceptions of the future prospects and financial health of Abbott Laboratories, and Abbott Laboratories fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Abbott Stock performance.
| Return On Equity | 0.31 | ||||
| Return On Asset | 0.0638 | ||||
| Profit Margin | 0.32 % | ||||
| Operating Margin | 0.19 % | ||||
| Current Valuation | 225.32 B | ||||
| Shares Outstanding | 1.74 B | ||||
| Price To Earning | 24.14 X | ||||
| Price To Book | 4.49 X | ||||
| Price To Sales | 5.08 X | ||||
| Revenue | 41.95 B | ||||
| Gross Profit | 24.21 B | ||||
| EBITDA | 10.83 B | ||||
| Net Income | 13.4 B | ||||
| Cash And Equivalents | 7.62 B | ||||
| Cash Per Share | 5.68 X | ||||
| Total Debt | 15.02 B | ||||
| Debt To Equity | 0.46 % | ||||
| Current Ratio | 1.86 X | ||||
| Book Value Per Share | 28.05 X | ||||
| Cash Flow From Operations | 8.56 B | ||||
| Earnings Per Share | 7.97 X | ||||
| Market Capitalization | 218.92 B | ||||
| Total Asset | 81.41 B | ||||
| Retained Earnings | 47.26 B | ||||
| Working Capital | 9.5 B | ||||
| Current Asset | 14.15 B | ||||
| Current Liabilities | 9.19 B | ||||
About Abbott Laboratories Performance
Assessing Abbott Laboratories' fundamental ratios provides investors with valuable insights into Abbott Laboratories' financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Abbott Laboratories is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 120.86 | 82.18 | |
| Return On Tangible Assets | 0.26 | 0.17 | |
| Return On Capital Employed | 0.10 | 0.10 | |
| Return On Assets | 0.16 | 0.13 | |
| Return On Equity | 0.28 | 0.26 |
Things to note about Abbott Laboratories performance evaluation
Checking the ongoing alerts about Abbott Laboratories for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Abbott Laboratories help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Abbott Laboratories generated a negative expected return over the last 90 days | |
| Over 81.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from finance.yahoo.com: CD40CD40L Inhibitors Market on Growth Trajectory Driven by Advancements in Autoimmune and Cancer Therapeutics DelveInsight |
- Analyzing Abbott Laboratories' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Abbott Laboratories' stock is overvalued or undervalued compared to its peers.
- Examining Abbott Laboratories' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Abbott Laboratories' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Abbott Laboratories' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Abbott Laboratories' stock. These opinions can provide insight into Abbott Laboratories' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Abbott Stock Analysis
When running Abbott Laboratories' price analysis, check to measure Abbott Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abbott Laboratories is operating at the current time. Most of Abbott Laboratories' value examination focuses on studying past and present price action to predict the probability of Abbott Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abbott Laboratories' price. Additionally, you may evaluate how the addition of Abbott Laboratories to your portfolios can decrease your overall portfolio volatility.